LPIN2 Polyclonal Antibody

Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance.

The LPIN2 Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of LPIN2 protein in various biological samples. This antibody is produced using high-quality polyclonal antibodies that have been purified and validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The LPIN2 Polyclonal Antibody is designed to recognize the LPIN2 protein, which is a key regulator of lipid metabolism and energy homeostasis. This protein is involved in the synthesis of phosphatidic acid, which is a critical intermediate in the biosynthesis of various lipids, including triglycerides and phospholipids.

The LPIN2 Polyclonal Antibody is highly specific and sensitive, allowing for the detection of LPIN2 protein in a variety of biological samples, including tissues, cells, and body fluids. This antibody has been extensively validated for use in various applications, ensuring reliable and reproducible results.

Overall, the LPIN2 Polyclonal Antibody is an essential tool for researchers studying lipid metabolism and energy homeostasis. Its high specificity and sensitivity make it an ideal choice for a wide range of applications, including basic research, drug discovery, and clinical diagnostics.